News
Shares of Centene (NYSE:CNC) lost ~10% in the early premarket trading on Friday after the Medicaid-driven managed care firm ...
Analysts have given Centene a total of 16 ratings, with the consensus rating being Neutral. The average one-year price target is $49.62, indicating a potential 68.66% upside.
Centene Corp (CNC) reports a mixed quarter with revenue growth but faces earnings pressure, while outlining strategic plans for margin recovery and future profitability.
Centene reported a $253 million loss in its second quarter as the provider of government-subsidized health benefits struggles ...
3d
ウォーカープラス on MSNMolina cuts 2025 earnings outlook again on ACA, Medicaid pressuresThe California-based insurer outlined its plans to survive what CEO Joe Zubretsky deemed a “season of great uncertainty” ...
Centene Corporation ( NYSE: CNC) Q2 2025 Earnings Conference Call July 25, 2025 8:30 AM ET a - Corporate Participant v - Corporate Participant Andrew Lynn Asher - Chief Financial Officer Jennifer ...
Analysts are estimating that Molina Healthcare will report an earnings per share (EPS) of $5.92. Investors in Molina ...
Centene stock tumbled after reporting a surprise Q2 loss, driven by rising medical costs and a weak outlook, shaking ...
Centene is responding by repricing plans for 2026 and focusing on cost controls while Medicare Advantage and Prescription ...
HCA Healthcare and Tenet Healthcare, for-profit chains that collectively own 240 hospitals, both said their revenue and ...
Centene’s stock pulled a sharp U-turn into the green, after the health insurer helped assuage investor worries by providing ...
Nasdaq and S&P 500 hover near highs as traders brace for next week’s Fed decision and earnings strength fuels optimism across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results